Blockade of HGF/c-Met signaling system using an HGF antagonist NK4, when combined with intraperitoneal chemotherapy, suppressed gastric cancer peritoneal metastases in nude mice and enhanced survival [118]. The gene discussed is MET; the disease is gastric cancer.